The advertisement promotes Fasenra, a medication, encouraging viewers to take action with a call to 'GET STARTED'.
Creative Information
| CID: | e17a31bf-e89f-486e-aa0a-13a78ae15aac |
| CRID: | 2_206_469100 |
| Domain: | astrazeneca.com |
| Seat: | BSW |
| Size: | 320x50 |
| Bid: | $0.49 |
| Timestamp: | 11/4/2025, 4:29:05 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/4/2025, 5:50:37 PM | 5.46s | |
| adomain_analysis | success | 11/4/2025, 5:50:20 PM | 4.49s | |
| adomain_capture | success | 11/4/2025, 5:50:16 PM | 0.18s | |
| ad_render | success | 11/4/2025, 5:50:32 PM | 16.66s | |
| brand_mapping | success | 11/4/2025, 4:29:07 PM | 0.12s | |
Analysis Results
| Size: | 320x50 | ||||||||||||||||||||||
| Data Transferred: | 1117.08 KB | ||||||||||||||||||||||
| Render Time: | 7.91 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Total Ad Size: | 1136.21 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Raw Ad Markup
<ins class='dcmads' style='display:inline-block;width:320px;height:50px' data-dcm-placement='N5622.3848558MATTERKIND/B32810878.409877191' data-dcm-rendering-mode='script' data-dcm-https-only data-dcm-keywords='a9f8f991-b413-11f0-a3b5-12736f8ce579' data-dcm-click-tracker='https%3A%2F%2Frtb.adentifi.com%2FClicks%3FcrId%3D469100%3BsId%3D805511%3BlId%3D108938%3BcId%3D18308%3BadExchange%3DBidSwitch%3Baction%3Dclick%3BadId%3Da9f8f991-b413-11f0-a3b5-12736f8ce579%3BadThdId%3Db29b543fa3e25f5fb982b9d8105a3ba4%3BengineId%3Di-0518379363586b4f5%3BdIp%3DOTguMTgyLjUzLjM0%3BdIpv6%3D%3BadThdIdCode%3DWEB_MD5_V4%3BdealId%3D0%3BgeoId%3D19901%3BinventoryId%3D5858412%3BrtdmIndicator%3D1%3Btimestamp%3D1761665699%3Blat%3DNDEuODI%3Blong%3DLTcxLjQ0%3Bdma%3DNTIx%3BstateCode%3D%3Bzip%3DMDI5MDk%3Bbsc%3D${CLICK_URL_ENC}%3Bredir%3D' data-dcm-resettable-device-id='' data-dcm-api-frameworks='[APIFRAMEWORKS]' data-dcm-omid-partner='[OMIDPARTNER]' data-dcm-gdpr-applies='gdpr=${GDPR}' data-dcm-gdpr-consent='gdpr_consent=${GDPR_CONSENT_755}' data-dcm-addtl-consent='addtl_consent=${ADDTL_CONSENT}' data-dcm-ltd='false' data-dcm-app-id=''> <script src='https://www.googletagservices.com/dcm/dcmads.js'></script></ins><img src='https://rtb.adentifi.com/Imps?impId=1;adId=a9f8f991-b413-11f0-a3b5-12736f8ce579;lId=108938;sId=805511;cId=18308;crId=469100;adThdId=b29b543fa3e25f5fb982b9d8105a3ba4;adExchange=BidSwitch;engineId=i-0518379363586b4f5;dealId=0;geoId=19901;inventoryId=5858412;rtdmIndicator=1;timestamp=1761665699;property=loveandlemons.com;dIp=OTguMTgyLjUzLjM0;dIpv6=;adThdIdCode=WEB_MD5_V4;thirdPartyIdType=1;npiKey=-3440375452088369805;hhId=420879458;cuid=cuid_c8b18b00-8636-11f0-9970-12db0105501f' style='display:none; width:0px; height:0px;' /><script src="https://tags.bkrtx.com/js/bk-coretag.js"></script><script>bk_addPageCtx("id","cuid_c8b18b00-8636-11f0-9970-12db0105501f");bk_allow_multiple_calls = true;bk_use_multiple_iframes = true;bk_send_statid_payload = true;bk_use_image = true;bk_callback = true;bk_doJSTag(18840, 4);</script><img src='https://sb.scorecardresearch.com/p?c1=9&c2=16077523&c3=2&cs_xi=cuid_c8b18b00-8636-11f0-9970-12db0105501f&rn=a9f8f991-b413-11f0-a3b5-12736f8ce579' height='0' width='0' /><span id="te-clearads-js-adtheorent01cont469100"><script type="text/javascript" src="//choices.truste.com/ca?pid=adtheorent01&aid=adtheorent01&cid=18308&c=adtheorent01cont469100&w=320&h=50&js=pmw0&plc=tr&uid=b29b543fa3e25f5fb982b9d8105a3ba4"></script></span><img src="https://us-east-sync.bidswitch.net/sync?ssp=kargo&dsp_id=206&imp=1" alt=" " style="display:none"/>Creatives
